Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Labovitz

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|April 19, 2017
Resting Heart Rate and Ischemic Stroke in Patients with Heart FailureKoki Nakanishi, Marco R Di Tullio, Min Qian, et al.
The American Journal of Cardiology|July 20, 2015
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or AspirinSiqin Ye, Bin Cheng, Gregory Y H Lip, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 26, 2016
Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF TrialTomoko S Kato, Marco R Di Tullio, Min Qian, et al.
Plos One|November 27, 2014
Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trialSusan Graham, Siqin Ye, Min Qian, et al.
Circulation. Heart Failure|April 9, 2015
Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudyShunichi Homma, John L P Thompson, Min Qian, et al.
The American Journal of Cardiology|July 25, 2018
Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)Tetz C Lee, Min Qian, Gregory Y H Lip, et al.
ESC Heart Failure|March 1, 2019
Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trialTetz C Lee, Min Qian, Lan Mu, et al.
JACC. Heart Failure|November 30, 2019
Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEFTetz C Lee, Min Qian, Yutong Liu, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 13, 2023
Risk of hemorrhagic transformation with early use of direct oral anticoagulants after acute ischemic stroke: A pooled analysis of prospective studies and randomized trialsAnas Alrohimi, David Z Rose, W Scott Burgin, et al.
The New England Journal of Medicine|May 4, 2012
Warfarin and aspirin in patients with heart failure and sinus rhythmShunichi Homma, John L P Thompson, Patrick M Pullicino, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Cerebrovascular Diseases (Basel, Switzerland)|April 19, 2017
Resting Heart Rate and Ischemic Stroke in Patients with Heart FailureKoki Nakanishi, Marco R Di Tullio, Min Qian, et al.
The American Journal of Cardiology|July 20, 2015
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or AspirinSiqin Ye, Bin Cheng, Gregory Y H Lip, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 26, 2016
Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF TrialTomoko S Kato, Marco R Di Tullio, Min Qian, et al.
Plos One|November 27, 2014
Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trialSusan Graham, Siqin Ye, Min Qian, et al.
Circulation. Heart Failure|April 9, 2015
Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudyShunichi Homma, John L P Thompson, Min Qian, et al.
The American Journal of Cardiology|July 25, 2018
Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)Tetz C Lee, Min Qian, Gregory Y H Lip, et al.
ESC Heart Failure|March 1, 2019
Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trialTetz C Lee, Min Qian, Lan Mu, et al.
JACC. Heart Failure|November 30, 2019
Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEFTetz C Lee, Min Qian, Yutong Liu, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 13, 2023
Risk of hemorrhagic transformation with early use of direct oral anticoagulants after acute ischemic stroke: A pooled analysis of prospective studies and randomized trialsAnas Alrohimi, David Z Rose, W Scott Burgin, et al.
The New England Journal of Medicine|May 4, 2012
Warfarin and aspirin in patients with heart failure and sinus rhythmShunichi Homma, John L P Thompson, Patrick M Pullicino, et al.
Pageof 18